ExploreWatchlistsPricing
  1. JP-listed companies
  2. KOKANDO CO.,LTD.
  3. Financials
  4. Net income

KOKANDO CO.,LTD. (E00959)

Market cap
P/E ratio
Kokan-do manufactures over-the-counter medicines like cold and stomach remedies, blending Toyama's traditional medicine heritage with modern pharmaceutical operations.
SummaryFinancialsDividendsHistoryWorkforce
Period EndNet income (Million JPY)YoY (%)
Mar 31, 202581-153.45%
Mar 31, 2024-152-92.16%
Mar 31, 2023-1,944+19.39%
Mar 31, 2022-1,629-7965.65%
Mar 31, 202121-91.90%
Mar 31, 2020255-75.70%
Mar 31, 20191,052+60.38%
Mar 31, 2018656-199.52%
Mar 31, 2017-659+419.01%
Mar 31, 2016-127-31.24%
Mar 31, 2015-185

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat